Side-by-side comparison of AI visibility scores, market position, and capabilities
Practice analytics and patient engagement platform for dental offices helping DSOs and independents grow production. American Fork UT; founded 2016; connects to 100+ dental PMS systems;
Dental Intelligence is an American Fork, Utah-based dental practice analytics and patient engagement platform that helps dental offices, group practices, and dental support organizations (DSOs) analyze production data, identify growth opportunities, and improve patient engagement and retention. Founded in 2016, the company built its platform around a core insight: most dental practices generate enormous amounts of operational data in their practice management software but lack the tools to turn that data into actionable insights. Dental Intelligence connects to over 100 dental practice management systems—including Dentrix, Eaglesoft, OpenDental, and Carestream—and automatically analyzes key performance indicators including production per provider, case acceptance rates, recall effectiveness, hygiene reappointment rates, and collections performance.\n\nThe platform's patient engagement tools allow dental practices to automate appointment reminders, recall outreach, and reactivation campaigns for patients who are overdue for cleanings or who have unscheduled treatment plans. These engagement automations reduce the manual administrative burden on front desk staff while improving patient show rates and reducing last-minute cancellations that disrupt production schedules. Dental Intelligence's analytics layer surfaces the specific operational levers most likely to drive revenue growth for each practice—whether that is improving treatment plan acceptance, filling hygiene chairs more efficiently, or reducing same-day cancellations.\n\nDental Intelligence has found particular traction with multi-location DSO customers that need consistent performance analytics and benchmarking across dozens or hundreds of dental practices. The platform's DSO-tier dashboards allow regional managers and corporate leadership to compare location performance, identify underperforming practices, and replicate the operational practices of top performers. The company competes with Weave, Solutionreach, and Carestream Dental in the dental technology market, differentiating on the depth of its practice analytics and its broad integration with existing dental practice management systems.
mRNA pioneer with $3.2B FY2024 revenue (down from $18.4B 2022 COVID peak); mRESVIA RSV vaccine approved 2024; personalized cancer vaccine with Merck shows 44% recurrence reduction in melanoma.
Moderna is a clinical-stage biotechnology company that pioneered the development of messenger RNA (mRNA) therapeutics and vaccines, founded in 2010 by Noubar Afeyan, Robert Langer, Kenneth Chien, Stéphane Bancel, and others in Cambridge, Massachusetts, where it is headquartered and trades on Nasdaq (MRNA). The company achieved extraordinary commercial success with Spikevax, its COVID-19 mRNA vaccine developed in partnership with the U.S. government in 2020—generating $18.4 billion in COVID vaccine revenues in 2022 at peak—before experiencing a severe revenue decline as global COVID booster demand normalized. For FY2024, Moderna generated approximately $3.2 billion in revenues, with Spikevax and the reformulated XBB.1.5-targeting COVID vaccine contributing the majority, while the company's significant R&D investment pipeline consumed most operating cash flows.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.